

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE HTML>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">
  <head>
    <meta content="text/html;charset=utf-8" http-equiv="Content-Type"/>
    <title>Immunization / All / CVX - JSON Representation - SMART Health Cards: Terminology v0.1.0</title>

    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <meta name="author" content="http://hl7.org/fhir"/>

    <link href="fhir.css" rel="stylesheet"/>

    <!-- Bootstrap core CSS -->
    <link href="assets/css/bootstrap-fhir.css" rel="stylesheet"/>

    <!-- Project extras -->
    <link href="assets/css/project.css" rel="stylesheet"/>
    <link href="assets/css/pygments-manni.css" rel="stylesheet"/>
    <link href="assets/css/jquery-ui.css" rel="stylesheet"/>
  	<link href="assets/css/prism.css" rel="stylesheet" />
    <!-- Placeholder for child template CSS declarations -->
    <link href="assets/css/fix-fonts.css" rel="stylesheet"/>
    <link href="assets/css/smart-health-cards.css" rel="stylesheet" />

    <script type="text/javascript" src="fhir-table-scripts.js"> </script>

    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
    <script src="assets/js/html5shiv.js"></script>
    <script src="assets/js/respond.min.js"></script>
    <![endif]-->

    <!-- Favicons -->
    <link rel="fhir-logo" sizes="144x144" href="assets/ico/icon-fhir-144.png"/>
    <link rel="fhir-logo" sizes="114x114" href="assets/ico/icon-fhir-114.png"/>
    <link rel="fhir-logo" sizes="72x72" href="assets/ico/icon-fhir-72.png"/>
    <link rel="fhir-logo" href="assets/ico/icon-fhir-57.png"/>
    <link rel="shortcut icon" href="assets/ico/favicon.png"/>
  </head>
  <body onload="document.body.style.opacity='1'">

	  <script src="assets/js/prism.js"></script>
    <script type="text/javascript" src="assets/js/mermaid.js"></script>
    <script type="text/javascript" src="assets/js/mermaid-init.js"></script>
    <style type="text/css">h2{--heading-prefix:"2.1"}
    h3,h4,h5,h6{--heading-prefix:"2.1"}</style>
    <div id="segment-header" class="segment">  <!-- segment-header -->
      <div class="container">  <!-- container -->
        <!-- Placeholder for child template header declarations -->


        <div id="ig-status">
          <p><span style="font-size:12pt;font-weight:bold">SMART Health Cards: Terminology</span>
            <br/>
            <span style="display:inline-block;">0.1.0 - ci-build


            </span>
          </p>
        </div>
      </div> <!-- /container -->
    </div>  <!-- /segment-header -->

    <div id="segment-navbar" class="segment">  <!-- segment-navbar -->
      <div id="stripe"> </div>
      <div class="container">  <!-- container -->
        <!-- HEADER CONTENT -->

        <nav class="navbar navbar-inverse">
          <!--status-bar-->
          <div class="container">
            <button data-target=".navbar-inverse-collapse" class="navbar-toggle" data-toggle="collapse" type="button">
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
            </button>
            <a class="navbar-brand hidden" href="http://hl7.org/fhir/R4/index.html">FHIR</a>
            <div class="nav-collapse collapse navbar-inverse-collapse">
              <!-- menu.xml  -->

<ul xmlns="http://www.w3.org/1999/xhtml" class="nav navbar-nav">
  <li>
    <a href="index.html">Home</a>
  </li>
  <li>
    <a href="artifacts.html">Artifacts</a>
  </li>
</ul>
            </div>  <!-- /.nav-collapse -->
          </div>  <!-- /.container -->
        </nav>  <!-- /.navbar -->
      <!-- /HEADER CONTENT -->
      </div>  <!-- /container -->
    </div>  <!-- /segment-navbar -->
    <!--status-bar-->

    <div id="segment-breadcrumb" class="segment">  <!-- segment-breadcrumb -->
      <div class="container">  <!-- container -->
        <ul class="breadcrumb">
          <li><a href='toc.html'><b>Table of Contents</b></a></li><li><a href='artifacts.html'><b>Artifacts Summary</b></a></li><li><b>Immunization / All / CVX</b></li>

        </ul>
      </div>  <!-- /container -->
    </div>  <!-- /segment-breadcrumb -->

    <a name="top"> </a>
    <div id="segment-content" class="segment">  <!-- segment-content -->
      <div class="container">  <!-- container -->
        <div class="row">
          <div class="inner-wrapper">

<div style="counter-reset: section 8" class="col-12">
<!--ReleaseHeader--><p id="publish-box">SMART Health Cards: Terminology - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the <a href="https://terminology.smarthealth.cards/history.html">Directory of published versions</a></p><!--EndReleaseHeader-->









<ul class="nav nav-tabs">

  <li>
    <a href="ValueSet-immunization-all-cvx.html">Narrative Content</a>
  </li>




  
    <li class="active">
      <a href="#">JSON</a>
    </li>
  




</ul>


<a name="root"> </a>


<h2 id="root">: Immunization / All / CVX - JSON Representation</h2>

  <table class="colsd">
    <tr>

      <td colspan="2">
        
          Draft
          
            as of 2024-11-22
          
        
      </td>

    </tr>
  </table>


<p><a href="ValueSet-immunization-all-cvx.json" no-download="true">Raw json</a> | <a href="ValueSet-immunization-all-cvx.json" download>Download</a></p>

  <!-- insert intro if present -->
  



  <pre class="json" style="white-space: pre; text-wrap: nowrap; width: auto;"><code style="white-space: pre; text-wrap: nowrap;">{
  "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet">resourceType</a>" : "ValueSet",
  "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.id">id</a>" : "immunization-all-cvx",
  "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.text">text</a>" : {
    "<a href="http://hl7.org/fhir/R4/datatypes.html#Narrative#Narrative.status">status</a>" : "extensions",
    "<a href="http://hl7.org/fhir/R4/datatypes.html#Narrative#Narrative.div">div</a>" : "&lt;div xmlns=\&quot;http://www.w3.org/1999/xhtml\&quot;&gt;\n        \n            &lt;p&gt;\n                The following codes from the &lt;code&gt;&lt;a href=\&quot;http://terminology.hl7.org/6.1.0/CodeSystem-CVX.html\&quot;&gt;http://hl7.org/fhir/sid/cvx&lt;/a&gt;&lt;/code&gt; code system are included:\n            &lt;/p&gt;\n            &lt;table class=\&quot;table-striped table table-bordered\&quot;&gt;\n                &lt;tr&gt;\n                    &lt;th&gt;Code&lt;/th&gt;\n                    &lt;th&gt;Description(s)&lt;/th&gt;\n                &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;54&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                adenovirus, type 4\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;55&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                adenovirus, type 7\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;82&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                adenovirus, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;24&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                anthrax\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;19&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                BCG\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;27&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                botulinum antitoxin\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;26&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                cholera, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;29&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                CMVIG\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;56&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                dengue fever tetravalent\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;12&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                diphtheria antitoxin\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;28&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DT (pediatric)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;20&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DTaP\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;106&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DTaP, 5 pertussis antigens\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;107&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DTaP, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;110&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DTaP-Hep B-IPV\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;50&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DTaP-Hib\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;120&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DTaP-Hib-IPV\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;130&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DTaP-IPV\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;1&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DTP\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;22&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DTP-Hib\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;102&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DTP-Hib-Hep B\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;57&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                hantavirus\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;52&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep A, adult\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;83&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep A, ped/adol, 2 dose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;84&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep A, ped/adol, 3 dose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;31&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep A, pediatric, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;85&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep A, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;104&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep A-Hep B\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;30&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                HBIG\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;8&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep B, adolescent or pediatric\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;42&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep B, adolescent/high risk infant\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;43&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep B, adult\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;44&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep B, dialysis\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;45&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep B, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;58&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep C\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;59&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep E\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;60&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                herpes simplex 2\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;46&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hib (PRP-D)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;47&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hib (HbOC)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;48&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hib (PRP-T)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;49&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hib (PRP-OMP)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;17&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hib, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;51&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hib-Hep B\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;61&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                HIV\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;118&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                HPV, bivalent\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;62&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                HPV, quadrivalent\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;86&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                IG\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;87&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                IGIV\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;14&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                IG, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;111&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, live, intranasal\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;15&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, split (incl. purified surface antigen)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;16&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, whole\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;88&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;123&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, H5N1-1203\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;10&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                IPV\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;2&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                OPV\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;89&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                polio, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;39&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Japanese encephalitis SC\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;63&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Junin virus\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;64&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                leishmaniasis\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;65&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                leprosy\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;66&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Lyme disease\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;3&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                MMR\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;4&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                M/R\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;94&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                MMRV\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;67&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                malaria\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;5&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                measles\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;68&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                melanoma\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;32&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                meningococcal MPSV4\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;103&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                meningococcal C conjugate\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;114&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                meningococcal MCV4P\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;108&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                meningococcal ACWY, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;7&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                mumps\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;69&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                parainfluenza-3\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;11&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                pertussis\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;23&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                plague\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;33&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                pneumococcal polysaccharide PPV23\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;100&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                pneumococcal conjugate PCV 7\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;109&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                pneumococcal, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;70&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Q fever\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;18&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                rabies, intramuscular injection\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;40&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                rabies, intradermal injection\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;90&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                rabies, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;72&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                rheumatic fever\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;73&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Rift Valley fever\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;34&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                RIG\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;119&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                rotavirus, monovalent\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;122&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                rotavirus, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;116&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                rotavirus, pentavalent\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;74&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                rotavirus, tetravalent\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;71&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                RSV-IGIV\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;93&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                RSV-MAb\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;6&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                rubella\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;38&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                rubella/mumps\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;76&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Staphylococcus bacterio lysate\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;113&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;9&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;115&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Tdap\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;35&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                tetanus toxoid, adsorbed\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;112&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                tetanus toxoid, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;77&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Tick-borne encephalitis vaccine (non-US)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;13&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                TIG\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;95&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                TST-OT tine test\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;96&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                TST-PPD intradermal\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;97&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                TST-PPD tine test\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;98&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                TST, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;78&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                tularemia vaccine\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;91&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                typhoid, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;25&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                typhoid, oral\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;41&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                typhoid, parenteral\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;53&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                typhoid, parenteral, AKD (U.S. military)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;101&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                typhoid, ViCPs\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;75&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                vaccinia (smallpox)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;105&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                vaccinia (smallpox) diluted\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;79&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                vaccinia immune globulin\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;21&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                varicella\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;81&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                VEE, inactivated\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;80&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                VEE, live\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;92&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                VEE, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;36&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                VZIG\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;117&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                VZIG (IND)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;37&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                yellow fever\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;121&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                zoster live\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;998&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                no vaccine administered\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;999&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                unknown\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;99&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                RESERVED - do not use\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;133&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Pneumococcal conjugate PCV 13\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;134&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Japanese Encephalitis IM\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;137&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                HPV, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;136&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Meningococcal MCV4O\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;135&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Influenza, high dose seasonal\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;131&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                typhus, historical\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;132&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DTaP-IPV-HIB-HEP B, historical\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;128&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Novel Influenza-H1N1-09, all formulations\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;125&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Novel Influenza-H1N1-09, nasal\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;126&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Novel influenza-H1N1-09, preservative-free\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;127&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Novel influenza-H1N1-09\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;138&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Td (adult)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;139&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Td(adult) unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;140&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Influenza, seasonal, injectable, preservative free\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;129&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Japanese Encephalitis, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;141&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Influenza, seasonal, injectable\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;142&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                tetanus toxoid, not adsorbed\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;143&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Adenovirus types 4 and 7\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;144&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, seasonal, intradermal, preservative free\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;145&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                RSV-MAb (new)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;146&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DTaP,IPV,Hib,HepB\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;147&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                meningococcal MCV4, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;148&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Meningococcal C/Y-HIB PRP\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;149&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, live, intranasal, quadrivalent\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;150&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, injectable, quadrivalent, preservative free\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;151&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza nasal, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;152&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Pneumococcal Conjugate, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;153&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Influenza, injectable, MDCK, preservative free\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;154&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep A, IG\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;155&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, recombinant, injectable, preservative free\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;156&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Rho(D)-IG\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;157&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Rho(D) -IG IM\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;158&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, injectable, quadrivalent\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;159&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Rho(D) - Unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;160&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Influenza A monovalent (H5N1), ADJUVANTED-2013\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;801&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                AS03 Adjuvant\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;161&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Influenza, injectable,quadrivalent, preservative free, pediatric\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;162&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                meningococcal B, recombinant\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;163&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                meningococcal B, OMV\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;164&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                meningococcal B, unspecified\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;165&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                HPV9\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;166&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, intradermal, quadrivalent, preservative free\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;167&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                meningococcal, unknown serogroups\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;168&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, trivalent, adjuvanted\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;169&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep A, live attenuated\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;170&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DTAP/IPV/HIB - non-US\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;171&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Influenza, injectable, MDCK, preservative free, quadrivalent\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;172&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                cholera, WC-rBS\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;173&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                cholera, BivWC\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;174&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                cholera, live attenuated\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;175&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Rabies - IM Diploid cell culture\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;176&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Rabies - IM fibroblast culture\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;177&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                PCV10\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;178&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                OPV bivalent\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;179&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                OPV ,monovalent, unspecified\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;180&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                tetanus immune globulin\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;181&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                anthrax immune globulin\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;182&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                OPV, Unspecified\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;183&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Yellow fever vaccine - alt\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;184&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Yellow fever, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;185&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, recombinant, quadrivalent,injectable, preservative free\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;186&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Influenza, injectable, MDCK, quadrivalent, preservative\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;187&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                zoster recombinant\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;188&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                zoster, unspecified formulation\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;189&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                HepB-CpG\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;190&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Typhoid conjugate vaccine (TCV)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;191&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                meningococcal A polysaccharide (non-US)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;192&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                meningococcal AC polysaccharide (non-US)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;193&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Hep A-Hep B, pediatric/adolescent\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;194&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Influenza, Southern Hemisphere\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;195&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DT, IPV adsorbed\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;196&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Td, adsorbed, preservative free, adult use, Lf unspecified\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;197&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, high-dose, quadrivalent\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;200&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, Southern Hemisphere, pediatric, preservative free\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;201&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, Southern Hemisphere, preservative free\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;202&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, Southern Hemisphere, quadrivalent, with preservative\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;198&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                DTP-hepB-Hib Pentavalent Non-US\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;203&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;205&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Influenza vaccine, quadrivalent, adjuvanted\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;206&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;207&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;208&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;213&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;210&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL \n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;212&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;204&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Ebola Zaire vaccine, live, recombinant, 1mL dose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;214&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Ebola, unspecified\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;211&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;500&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 Non-US Vaccine, Product Unknown\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;501&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 IV Non-US Vaccine (QAZCOVID-IN)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;502&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 IV Non-US Vaccine (COVAXIN)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;503&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 LAV Non-US Vaccine (COVIVAC)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;504&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 VVnr Non-US Vaccine (Sputnik Light)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;505&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 VVnr Non-US Vaccine (Sputnik V)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;506&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;507&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;508&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;509&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 PS Non-US Vaccine (EpiVacCorona)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;510&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;511&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;215&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;216&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;219&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;217&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;218&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;220&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                HepB recombinant, 3-antigen, Al(OH)3\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;221&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;222&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Tick-borne encephalitis, unspecified\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;223&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Tick-borne encephalitis, inactivated, PF, 0.25mL\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;224&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Tick-borne encephalitis, inactivated, PF, 0.5mL\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;225&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;226&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;512&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;513&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;514&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;515&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;516&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;517&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;227&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;228&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;229&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;301&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;300&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;230&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;518&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;519&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;520&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;521&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;231&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                influenza, Southern Hemisphere, high-dose, quadrivalent\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;303&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;304&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                Respiratory syncytial virus (RSV), unspecified \n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;305&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;306&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;307&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;313&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;308&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;309&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;310&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;312&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;311&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n                    &lt;tr&gt;\n                        &lt;td&gt;&lt;code&gt;302&lt;/code&gt;&lt;/td&gt;\n                        &lt;td&gt;\n                            \n                                COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose\n                            \n                        &lt;/td&gt;\n                    &lt;/tr&gt;\n                \n            &lt;/table&gt;\n        \n&lt;/div&gt;"
  },
  "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.url">url</a>" : "https://terminology.smarthealth.cards/ValueSet/immunization-all-cvx",
  "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.version">version</a>" : "20230920",
  "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.name">name</a>" : "ImmunizationAllCvxValueSet",
  "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.title">title</a>" : "Immunization / All / CVX",
  "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.status">status</a>" : "draft",
  "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.date">date</a>" : "2024-11-22T10:51:11+00:00",
  "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.publisher">publisher</a>" : "VCI",
  "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.contact">contact</a>" : [
    {
      "<a href="http://hl7.org/fhir/R4/metadatatypes.html#ContactDetail#ContactDetail.name">name</a>" : "VCI",
      "<a href="http://hl7.org/fhir/R4/metadatatypes.html#ContactDetail#ContactDetail.telecom">telecom</a>" : [
        {
          "<a href="http://hl7.org/fhir/R4/datatypes.html#ContactPoint#ContactPoint.system">system</a>" : "url",
          "<a href="http://hl7.org/fhir/R4/datatypes.html#ContactPoint#ContactPoint.value">value</a>" : "https://vci.org"
        }
      ]
    }
  ],
  "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.description">description</a>" : "Contains all CVX codes from &lt;https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx&gt; as of 2023-09-20.",
  "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose">compose</a>" : {
    "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include">include</a>" : [
      {
        "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.system">system</a>" : "http://hl7.org/fhir/sid/cvx",
        "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept">concept</a>" : [
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "54",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "adenovirus, type 4"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "55",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "adenovirus, type 7"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "82",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "adenovirus, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "24",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "anthrax"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "19",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "BCG"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "27",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "botulinum antitoxin"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "26",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "cholera, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "29",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "CMVIG"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "56",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "dengue fever tetravalent"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "12",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "diphtheria antitoxin"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "28",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DT (pediatric)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "20",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DTaP"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "106",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DTaP, 5 pertussis antigens"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "107",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DTaP, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "110",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DTaP-Hep B-IPV"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "50",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DTaP-Hib"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "120",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DTaP-Hib-IPV"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "130",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DTaP-IPV"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "1",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DTP"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "22",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DTP-Hib"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "102",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DTP-Hib-Hep B"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "57",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "hantavirus"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "52",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep A, adult"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "83",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep A, ped/adol, 2 dose"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "84",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep A, ped/adol, 3 dose"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "31",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep A, pediatric, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "85",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep A, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "104",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep A-Hep B"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "30",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "HBIG"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "8",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep B, adolescent or pediatric"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "42",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep B, adolescent/high risk infant"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "43",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep B, adult"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "44",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep B, dialysis"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "45",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep B, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "58",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep C"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "59",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep E"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "60",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "herpes simplex 2"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "46",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hib (PRP-D)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "47",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hib (HbOC)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "48",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hib (PRP-T)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "49",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hib (PRP-OMP)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "17",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hib, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "51",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hib-Hep B"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "61",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "HIV"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "118",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "HPV, bivalent"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "62",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "HPV, quadrivalent"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "86",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "IG"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "87",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "IGIV"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "14",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "IG, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "111",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, live, intranasal"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "15",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, split (incl. purified surface antigen)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "16",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, whole"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "88",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "123",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, H5N1-1203"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "10",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "IPV"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "2",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "OPV"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "89",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "polio, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "39",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Japanese encephalitis SC"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "63",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Junin virus"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "64",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "leishmaniasis"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "65",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "leprosy"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "66",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Lyme disease"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "3",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "MMR"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "4",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "M/R"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "94",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "MMRV"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "67",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "malaria"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "5",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "measles"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "68",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "melanoma"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "32",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "meningococcal MPSV4"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "103",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "meningococcal C conjugate"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "114",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "meningococcal MCV4P"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "108",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "meningococcal ACWY, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "7",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "mumps"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "69",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "parainfluenza-3"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "11",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "pertussis"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "23",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "plague"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "33",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "pneumococcal polysaccharide PPV23"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "100",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "pneumococcal conjugate PCV 7"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "109",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "pneumococcal, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "70",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Q fever"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "18",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "rabies, intramuscular injection"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "40",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "rabies, intradermal injection"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "90",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "rabies, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "72",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "rheumatic fever"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "73",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Rift Valley fever"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "34",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "RIG"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "119",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "rotavirus, monovalent"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "122",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "rotavirus, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "116",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "rotavirus, pentavalent"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "74",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "rotavirus, tetravalent"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "71",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "RSV-IGIV"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "93",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "RSV-MAb"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "6",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "rubella"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "38",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "rubella/mumps"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "76",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Staphylococcus bacterio lysate"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "113",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "9",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "115",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Tdap"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "35",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "tetanus toxoid, adsorbed"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "112",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "tetanus toxoid, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "77",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Tick-borne encephalitis vaccine (non-US)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "13",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "TIG"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "95",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "TST-OT tine test"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "96",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "TST-PPD intradermal"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "97",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "TST-PPD tine test"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "98",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "TST, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "78",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "tularemia vaccine"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "91",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "typhoid, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "25",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "typhoid, oral"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "41",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "typhoid, parenteral"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "53",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "typhoid, parenteral, AKD (U.S. military)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "101",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "typhoid, ViCPs"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "75",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "vaccinia (smallpox)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "105",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "vaccinia (smallpox) diluted"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "79",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "vaccinia immune globulin"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "21",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "varicella"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "81",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "VEE, inactivated"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "80",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "VEE, live"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "92",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "VEE, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "36",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "VZIG"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "117",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "VZIG (IND)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "37",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "yellow fever"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "121",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "zoster live"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "998",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "no vaccine administered"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "999",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "unknown"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "99",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "RESERVED - do not use"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "133",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Pneumococcal conjugate PCV 13"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "134",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Japanese Encephalitis IM"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "137",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "HPV, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "136",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Meningococcal MCV4O"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "135",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Influenza, high dose seasonal"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "131",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "typhus, historical"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "132",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DTaP-IPV-HIB-HEP B, historical"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "128",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Novel Influenza-H1N1-09, all formulations"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "125",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Novel Influenza-H1N1-09, nasal"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "126",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Novel influenza-H1N1-09, preservative-free"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "127",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Novel influenza-H1N1-09"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "138",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Td (adult)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "139",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Td(adult) unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "140",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Influenza, seasonal, injectable, preservative free"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "129",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Japanese Encephalitis, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "141",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Influenza, seasonal, injectable"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "142",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "tetanus toxoid, not adsorbed"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "143",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Adenovirus types 4 and 7"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "144",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, seasonal, intradermal, preservative free"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "145",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "RSV-MAb (new)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "146",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DTaP,IPV,Hib,HepB"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "147",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "meningococcal MCV4, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "148",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Meningococcal C/Y-HIB PRP"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "149",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, live, intranasal, quadrivalent"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "150",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, injectable, quadrivalent, preservative free"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "151",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza nasal, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "152",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Pneumococcal Conjugate, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "153",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Influenza, injectable, MDCK, preservative free"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "154",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep A, IG"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "155",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, recombinant, injectable, preservative free"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "156",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Rho(D)-IG"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "157",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Rho(D) -IG IM"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "158",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, injectable, quadrivalent"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "159",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Rho(D) - Unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "160",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Influenza A monovalent (H5N1), ADJUVANTED-2013"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "801",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "AS03 Adjuvant"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "161",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Influenza, injectable,quadrivalent, preservative free, pediatric"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "162",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "meningococcal B, recombinant"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "163",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "meningococcal B, OMV"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "164",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "meningococcal B, unspecified"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "165",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "HPV9"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "166",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, intradermal, quadrivalent, preservative free"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "167",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "meningococcal, unknown serogroups"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "168",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, trivalent, adjuvanted"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "169",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep A, live attenuated"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "170",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DTAP/IPV/HIB - non-US"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "171",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Influenza, injectable, MDCK, preservative free, quadrivalent"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "172",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "cholera, WC-rBS"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "173",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "cholera, BivWC"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "174",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "cholera, live attenuated"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "175",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Rabies - IM Diploid cell culture"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "176",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Rabies - IM fibroblast culture"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "177",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "PCV10"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "178",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "OPV bivalent"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "179",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "OPV ,monovalent, unspecified"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "180",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "tetanus immune globulin"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "181",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "anthrax immune globulin"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "182",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "OPV, Unspecified"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "183",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Yellow fever vaccine - alt"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "184",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Yellow fever, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "185",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, recombinant, quadrivalent,injectable, preservative free"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "186",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Influenza, injectable, MDCK, quadrivalent, preservative"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "187",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "zoster recombinant"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "188",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "zoster, unspecified formulation"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "189",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "HepB-CpG"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "190",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Typhoid conjugate vaccine (TCV)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "191",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "meningococcal A polysaccharide (non-US)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "192",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "meningococcal AC polysaccharide (non-US)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "193",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Hep A-Hep B, pediatric/adolescent"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "194",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Influenza, Southern Hemisphere"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "195",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DT, IPV adsorbed"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "196",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Td, adsorbed, preservative free, adult use, Lf unspecified"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "197",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, high-dose, quadrivalent"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "200",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, Southern Hemisphere, pediatric, preservative free"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "201",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, Southern Hemisphere, preservative free"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "202",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, Southern Hemisphere, quadrivalent, with preservative"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "198",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "DTP-hepB-Hib Pentavalent Non-US"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "203",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "205",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Influenza vaccine, quadrivalent, adjuvanted"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "206",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "207",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "208",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "213",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "210",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL "
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "212",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "204",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Ebola Zaire vaccine, live, recombinant, 1mL dose"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "214",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Ebola, unspecified"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "211",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "500",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 Non-US Vaccine, Product Unknown"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "501",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 IV Non-US Vaccine (QAZCOVID-IN)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "502",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 IV Non-US Vaccine (COVAXIN)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "503",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 LAV Non-US Vaccine (COVIVAC)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "504",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 VVnr Non-US Vaccine (Sputnik Light)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "505",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 VVnr Non-US Vaccine (Sputnik V)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "506",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "507",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "508",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "509",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 PS Non-US Vaccine (EpiVacCorona)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "510",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "511",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "215",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "216",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "219",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "217",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "218",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "220",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "HepB recombinant, 3-antigen, Al(OH)3"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "221",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "222",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Tick-borne encephalitis, unspecified"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "223",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Tick-borne encephalitis, inactivated, PF, 0.25mL"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "224",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Tick-borne encephalitis, inactivated, PF, 0.5mL"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "225",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "226",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "512",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "513",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "514",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "515",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "516",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "517",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "227",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "228",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "229",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "301",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "300",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "230",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "518",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "519",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "520",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "521",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "231",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "influenza, Southern Hemisphere, high-dose, quadrivalent"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "303",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "304",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "Respiratory syncytial virus (RSV), unspecified "
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "305",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "306",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "307",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "313",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "308",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "309",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "310",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "312",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "311",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL"
          },
          {
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.code">code</a>" : "302",
            "<a href="http://hl7.org/fhir/R4/valueset.html#ValueSet.compose.include.concept.display">display</a>" : "COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose"
          }
        ]
      }
    ]
  }
}</code></pre>


  <!-- insert notes if present -->
  



</div>
        </div>  <!-- /inner-wrapper -->
      </div>  <!-- /row -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-content -->

  <script type="text/javascript" src="assets/js/jquery.js"> </script>     <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
  <script type="text/javascript" src="assets/js/jquery-ui.min.js"> </script>

  <script type="text/javascript" src="assets/js/window-hash.js"> </script>
  <a name="bottom"> </a>
  <div id="segment-footer" igtool="footer" class="segment">  <!-- segment-footer -->
    <div class="container">  <!-- container -->

      <div class="inner-wrapper">
        <p>
          IG &#169; 2022+ <a style="color:var(--footer-hyperlink-text-color)" href="https://vci.org">VCI</a>.  Package cards.smarthealth.terminology#0.1.0 based on <a style="color: var(--footer-hyperlink-text-color)" href="http://hl7.org/fhir/R4/">FHIR 4.0.1</a>. Generated <span title="Fri, Nov 22, 2024 10:51+0000">2024-11-22</span>
          <br/>
          <span style="color: var(--footer-highlight-text-color)">
                      Links: <a style="color: var(--footer-hyperlink-text-color)" href="toc.html">Table of Contents</a> |
                 <a style="color: var(--footer-hyperlink-text-color)" href="qa.html">QA Report</a>
                 
                
          </span>
        </p>
      </div>  <!-- /inner-wrapper -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-footer -->
  
  <div id="segment-post-footer" class="segment hidden">  <!-- segment-post-footer -->
    <div class="container">  <!-- container -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-post-footer -->

  <!-- JS and analytics only. -->
  <!-- Bootstrap core JavaScript
  ================================================== -->
  <!-- Placed at the end of the document so the pages load faster -->
  <script type="text/javascript" src="assets/js/bootstrap.min.js"> </script>
  <script type="text/javascript" src="assets/js/respond.min.js"> </script>
  <script type="text/javascript" src="assets/js/anchor.min.js"> </script>
  <script type="text/javascript" src="assets/js/clipboard.min.js"> </script>
  <script type="text/javascript" src="assets/js/clipboard-btn.js"> </script>
  <script type="text/javascript" src="assets/js/anchor-hover.js"> </script>
  <!-- Analytics Below
  ================================================== -->
  </body>
</html>

